Chemours Co (CC) Stock
2 members of Congress disclosed 4 trades in CC since 2017: 2 purchases and 2 sales, most recently Michael C. Burgess (purchase, Aug 9, 2023). 7 of the hedge funds AlphaScala tracks reported CC in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is D.E. Shaw's at $58.89M. Company insiders reported 6 open-market buys and 0 sales on SEC Form 4 in the 90 days to Nov 3, 2026.
Which members of Congress traded Chemours Co (CC)?
Most recent: Michael C. Burgess (purchase, Aug 9, 2023); records start Oct 10, 2017.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Michael Burgess R-TX · House | 2023-08-09 | purchase | $15k – $50k |
| Michael Burgess R-TX · House | 2023-07-06 | partial sale | $1k – $15k |
| Michael Burgess R-TX · House | 2023-07-06 | purchase | $15k – $50k |
| Tammy Duckworth D-IL · Senate | 2017-10-10 | sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 2, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all CC political trades →Which hedge funds own CC?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| D.E. Shaw David Shaw | 2.87M | $58.89M | +1% |
| Marshall Wace | 1.19M | $24.46M | -5% |
| Millennium Management Israel Englander | 473K | $9.71M | +29% |
| Point72 Steve Cohen | 195K | $4.00M | -68% |
| Blackstone | 67K | $1.37M | NEW |
| Bridgewater Associates Ray Dalio | 40K | $811.7K | -74% |
| Citadel Ken Griffin | 14K | $288.4K | -95% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Chemours Co insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 12, 26 | Familiar Calderon Gerardo | See Remarks | BUY | 1.9K | $30K |
| Aug 11, 26 | Dignam Denise | Chief Executive Officer | BUY | 3.4K | $51K |
| Aug 7, 26 | Cranston Mary B | Director | BUY | 6.0K | $95K |
| Aug 7, 26 | Martinko Joseph T. | See Remarks | BUY | 1.9K | $30K |
| Aug 7, 26 | Foley Michael Robert | See Remarks | BUY | 1.9K | $30K |
| Aug 7, 26 | Cowan Alister | Director | BUY | 13.0K | $203K |
| Aug 6, 26 | Hostetter Shane | Chief Financial Officer | BUY | 3.4K | $50K |
SEC Form 4 filings as of Nov 3, 2026
See cluster-buy signals across all tickers →CC price chart
Powered by TradingViewWhat does Chemours Co do?
Chemours Co. is a global provider of performance chemicals, delivering customized industrial and specialty chemical solutions across diverse markets. The company operates through three core segments: Titanium Technologies, which produces titanium dioxide (TiO2) pigment for applications requiring whiteness, brightness, opacity, and durability in paints, coatings, plastics, and paper; Thermal & Specialized Solutions, offering refrigerants, cooling and heating products, and industrial chemicals for refrigeration, air conditioning, mining, and metals processing; and Advanced Performance Materials, supplying fluoropolymers and fluorinated surfactants for high-technology uses in semiconductors, automotive components, electronics, and more. Chemours Co. serves industries including automotive, construction, electronics, packaging, and general manufacturing, with a focus on products that support energy efficiency and environmental goals. Headquartered in Wilmington, Delaware, and founded in 2015, the company maintains manufacturing facilities and research centers worldwide, primarily generating revenue from North America.